Cognex (NASDAQ:CGNX) Given New $84.00 Price Target at Cantor Fitzgerald

Key Points

• Cantor Fitzgerald raised Cognex’s price target from $76 to $84 while maintaining an “overweight” rating, implying 24.67% upside from the reported $67.38 share price.
• Analyst sentiment is broadly positive: Cognex has a consensus “Moderate Buy” rating and an average price target of $73.92, with recent upgrades and target increases from JPMorgan, Barclays and Needham.
• Cognex reported quarterly EPS of $0.45, beating estimates by $0.03, while revenue increased 16.9% year over year. However, insiders sold roughly $15 million of stock over the past 90 days.

Cognex (NASDAQ:CGNX - Get Free Report) had its target price raised by equities researchers at Cantor Fitzgerald from $76.00 to $84.00 in a research note issued on Friday,Benzinga reports. The firm presently has an "overweight" rating on the scientific and technical instruments company's stock. Cantor Fitzgerald's price objective would indicate a potential upside of 24.67% from the company's current price.

A number of other analysts have also recently commented on CGNX. Weiss Ratings reiterated a "hold (c)" rating on shares of Cognex in a research note on Friday, May 15th. DA Davidson set a $62.00 price target on Cognex and gave the stock a "neutral" rating in a report on Thursday, May 14th. Needham & Company LLC upped their price objective on Cognex from $67.00 to $75.00 and gave the company a "buy" rating in a research note on Friday, May 8th. JPMorgan Chase & Co. upgraded Cognex from a "neutral" rating to an "overweight" rating and lifted their target price for the stock from $65.00 to $75.00 in a research note on Tuesday, May 26th. Finally, Barclays reissued an "overweight" rating and set a $75.00 target price (up from $64.00) on shares of Cognex in a report on Monday, May 11th. Two investment analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and four have issued a Hold rating to the company's stock. According to data from MarketBeat, Cognex presently has a consensus rating of "Moderate Buy" and an average target price of $73.92.

Cognex Price Performance

Shares of NASDAQ CGNX opened at $67.38 on Friday. The business has a 50-day moving average of $64.99 and a 200-day moving average of $57.09. The stock has a market capitalization of $11.21 billion, a price-to-earnings ratio of 65.42 and a beta of 1.49. Cognex has a fifty-two week low of $34.60 and a fifty-two week high of $72.88.

Cognex (NASDAQ:CGNX - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.42 by $0.03. The firm had revenue of $291.26 million during the quarter, compared to analysts' expectations of $292.10 million. Cognex had a return on equity of 13.82% and a net margin of 16.05%.During the same period in the prior year, the firm posted $0.25 earnings per share. The business's quarterly revenue was up 16.9% compared to the same quarter last year. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. On average, sell-side analysts expect that Cognex will post 1.48 EPS for the current year.

Insider Activity at Cognex

In related news, VP Darren Marc Long sold 20,252 shares of the firm's stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the transaction, the vice president directly owned 3,990 shares of the company's stock, valued at approximately $264,696.60. This trade represents a 83.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Mark Fennell sold 64,873 shares of the business's stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $67.05, for a total transaction of $4,349,734.65. Following the completion of the sale, the insider directly owned 11,263 shares of the company's stock, valued at $755,184.15. This represents a 85.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 224,847 shares of company stock worth $14,975,098 in the last ninety days. 1.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On Cognex

Several institutional investors have recently made changes to their positions in the stock. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in Cognex during the 2nd quarter worth $26,000. Elevation Wealth Partners LLC lifted its position in shares of Cognex by 635.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 478 shares of the scientific and technical instruments company's stock valued at $35,000 after acquiring an additional 413 shares during the period. FNY Investment Advisers LLC acquired a new stake in shares of Cognex during the 2nd quarter worth $45,000. Cassaday & Co Wealth Management LLC acquired a new stake in shares of Cognex during the 1st quarter worth $36,000. Finally, CIBC Private Wealth Group LLC increased its position in shares of Cognex by 74.8% in the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company's stock worth $35,000 after purchasing an additional 327 shares during the period. 88.12% of the stock is currently owned by institutional investors.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company's product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source